These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836 [TBL] [Abstract][Full Text] [Related]
8. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis. Kuyper LM; Khan NA Can J Cardiol; 2014 May; 30(5 Suppl):S47-53. PubMed ID: 24750981 [TBL] [Abstract][Full Text] [Related]
9. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. van der Woude HJ; Zaagsma J; Postma DS; Winter TH; van Hulst M; Aalbers R Chest; 2005 Mar; 127(3):818-24. PubMed ID: 15764762 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct]. Tomov I Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044 [No Abstract] [Full Text] [Related]
11. The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials. Wang X; Feng W; Zhao X; Liu Z; Dong L Dermatology; 2021; 237(3):433-443. PubMed ID: 33027794 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies. Lin Z; Zhang B; Yu Z; Li H Br J Clin Pharmacol; 2020 Feb; 86(2):199-209. PubMed ID: 31833573 [TBL] [Abstract][Full Text] [Related]
13. [Effects of beta blockaders on ventilatory function in chronic bronchitis]. Hugues FC; Julien D; Marche J Arch Mal Coeur Vaiss; 1979 Jan; 72(1):92-7. PubMed ID: 35114 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease. Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059 [TBL] [Abstract][Full Text] [Related]
15. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249 [TBL] [Abstract][Full Text] [Related]
16. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation. Conjeevaram R; Chaturvedula A; Betageri GV; Sunkara G; Banga AK Pharm Res; 2003 Sep; 20(9):1496-501. PubMed ID: 14567646 [TBL] [Abstract][Full Text] [Related]
18. Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients. Pujet JC; Dubreuil C; Fleury B; Provendier O; Abella ML Eur Respir J; 1992 Feb; 5(2):196-200. PubMed ID: 1348481 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits. Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031 [TBL] [Abstract][Full Text] [Related]
20. beta-adrenoceptor antagonism and intraocular pressure. A clinical study on propranolol, practolol and atenolol. Wettrell K Acta Ophthalmol Suppl; 1977; (134):1-54. PubMed ID: 22980 [No Abstract] [Full Text] [Related] [Next] [New Search]